Our researchers want to help people fall asleep faster.
Stanford has partnered with Eisai and UCSF to explore the potential benefits of a medication called Lemborexant in delayed sleep phase syndrome. Lemborexant is a melatonin agonist currently used to treat insomnia. If you want to go to sleep 2 hours or more before you usually do, but cannot fall asleep any earlier, you may have delayed sleep phase syndrome and could be eligible for this study.
Participating in this research study may help investigators to develop better treatments for delayed sleep phase syndrome in the future. Join our compensated study today!